Global Glutamate Receptor Ionotropic NMDA 2B Market By Product Type (JNJ-0808, Neu-2000) And By End-Users/Application (Acute Ischemic Stroke, Autism) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Glutamate Receptor Ionotropic NMDA 2B market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Glutamate Receptor Ionotropic NMDA 2B market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Glutamate Receptor Ionotropic NMDA 2B industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Glutamate Receptor Ionotropic NMDA 2B ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Glutamate Receptor Ionotropic NMDA 2B market.

The following manufacturers are covered in this report:
  • BioCrea GmbH
  • Bristol-Myers Squibb Company
  • Cerecor Inc.
  • Johnson & Johnson
  • Luc Therapeutics, Inc.
  • NeurOp, Inc
  • Novartis AG
  • UCB S.A.

The report estimates on the Glutamate Receptor Ionotropic NMDA 2B market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Glutamate Receptor Ionotropic NMDA 2B market report consist of all leading industry players, Glutamate Receptor Ionotropic NMDA 2B business sections, company profile, revenue supply by Glutamate Receptor Ionotropic NMDA 2B industry sections, global Glutamate Receptor Ionotropic NMDA 2B market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Glutamate Receptor Ionotropic NMDA 2B market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Glutamate Receptor Ionotropic NMDA 2B market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Glutamate Receptor Ionotropic NMDA 2B market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Glutamate Receptor Ionotropic NMDA 2B market.

Report Opportunity: Global Glutamate Receptor Ionotropic NMDA 2B Market

This report delivers an analytical examination of the Glutamate Receptor Ionotropic NMDA 2B market summarized in broad sections such as
  1. Glutamate Receptor Ionotropic NMDA 2B Market Summary
  2. Key Commercial Growths in the Glutamate Receptor Ionotropic NMDA 2B Industry
  3. Market Dynamics Affecting the Glutamate Receptor Ionotropic NMDA 2B Industry
  4. Important Market Trends and Future Development Scenario of the Glutamate Receptor Ionotropic NMDA 2B Market
  5. Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Glutamate Receptor Ionotropic NMDA 2B Industry
  7. Positioning of Main Market Players in the Glutamate Receptor Ionotropic NMDA 2B Industry
  8. Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast, by Application, 2018 - 2028
  9. Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast, by Geography, 2018 - 2028
Glutamate Receptor Ionotropic NMDA 2B Market Segmentation:

The report provides detailed examination of the Glutamate Receptor Ionotropic NMDA 2B market on the basis of various segments such as type, application and end-use industry. The Glutamate Receptor Ionotropic NMDA 2B market is segmented as follows:

Glutamate Receptor Ionotropic NMDA 2B Market, by Type:
  • JNJ-0808
  • Neu-2000
  • NP-10679
  • NP-11948
  • Radiprodil
  • Others
Glutamate Receptor Ionotropic NMDA 2B Market, by Application:
  • Acute Ischemic Stroke
  • Autism
  • Brasin Ischemia
  • Burns
  • Others
Geographic Coverage

The report on the Glutamate Receptor Ionotropic NMDA 2B market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast
  • U.S.
  • Canada
Europe Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Glutamate Receptor Ionotropic NMDA 2B Market Snapshot
          2.1.1. Global Glutamate Receptor Ionotropic NMDA 2B Market By Type,2019
               2.1.1.1.JNJ-0808
               2.1.1.2.Neu-2000
               2.1.1.3.NP-10679
               2.1.1.4.NP-11948
               2.1.1.5.Radiprodil
               2.1.1.6.Others
          2.1.2. Global Glutamate Receptor Ionotropic NMDA 2B Market By Application,2019
               2.1.2.1.Acute Ischemic Stroke
               2.1.2.2.Autism
               2.1.2.3.Brasin Ischemia
               2.1.2.4.Burns
               2.1.2.5.Others
          2.1.3. Global Glutamate Receptor Ionotropic NMDA 2B Market By End-use,2019
          2.1.4. Global Glutamate Receptor Ionotropic NMDA 2B Market By Geography,2019

3. Global Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028

5. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028

6. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028

7. Global Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Glutamate Receptor Ionotropic NMDA 2B Market Analysis, 2018 – 2028 
          7.2.1. North America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Glutamate Receptor Ionotropic NMDA 2B Market Analysis, 2018 – 2028 
          7.3.1.  Europe Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Glutamate Receptor Ionotropic NMDA 2B Market Analysis, 2018 – 2028 
          7.6.1.  MEA Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Glutamate Receptor Ionotropic NMDA 2B Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Glutamate Receptor Ionotropic NMDA 2B Providers
        8.4.1 BioCrea GmbH
                8.1.1 Business Description
                8.1.2 BioCrea GmbH Geographic Operations
                8.1.3 BioCrea GmbH Financial Information
                8.1.4 BioCrea GmbH Product Positions/Portfolio
                8.1.5 BioCrea GmbH Key Developments
        8.4.2 Bristol-Myers Squibb Company
                8.2.1 Business Description
                8.2.2 Bristol-Myers Squibb Company Geographic Operations
                8.2.3 Bristol-Myers Squibb Company Financial Information
                8.2.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.2.5 Bristol-Myers Squibb Company Key Developments
        8.4.3 Cerecor Inc.
                8.3.1 Business Description
                8.3.2 Cerecor Inc. Geographic Operations
                8.3.3 Cerecor Inc. Financial Information
                8.3.4 Cerecor Inc. Product Positions/Portfolio
                8.3.5 Cerecor Inc. Key Developments
        8.4.4 Johnson & Johnson
                8.4.1 Business Description
                8.4.2 Johnson & Johnson Geographic Operations
                8.4.3 Johnson & Johnson Financial Information
                8.4.4 Johnson & Johnson Product Positions/Portfolio
                8.4.5 Johnson & Johnson Key Developments
        8.4.5 Luc Therapeutics, Inc.
                8.5.1 Business Description
                8.5.2 Luc Therapeutics, Inc. Geographic Operations
                8.5.3 Luc Therapeutics, Inc. Financial Information
                8.5.4 Luc Therapeutics, Inc. Product Positions/Portfolio
                8.5.5 Luc Therapeutics, Inc. Key Developments
        8.4.6 NeurOp, Inc
                8.6.1 Business Description
                8.6.2 NeurOp, Inc Geographic Operations
                8.6.3 NeurOp, Inc Financial Information
                8.6.4 NeurOp, Inc Product Positions/Portfolio
                8.6.5 NeurOp, Inc Key Developments
        8.4.7 Novartis AG
                8.7.1 Business Description
                8.7.2 Novartis AG Geographic Operations
                8.7.3 Novartis AG Financial Information
                8.7.4 Novartis AG Product Positions/Portfolio
                8.7.5 Novartis AG Key Developments
        8.4.8 UCB S.A.
                8.8.1 Business Description
                8.8.2 UCB S.A. Geographic Operations
                8.8.3 UCB S.A. Financial Information
                8.8.4 UCB S.A. Product Positions/Portfolio
                8.8.5 UCB S.A. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Glutamate Receptor Ionotropic NMDA 2B Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Glutamate Receptor Ionotropic NMDA 2B Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Glutamate Receptor Ionotropic NMDA 2B: Market Segmentation 
FIG. 2 Global Glutamate Receptor Ionotropic NMDA 2B Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Glutamate Receptor Ionotropic NMDA 2B Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Glutamate Receptor Ionotropic NMDA 2B Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Glutamate Receptor Ionotropic NMDA 2B Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Glutamate Receptor Ionotropic NMDA 2B Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Glutamate Receptor Ionotropic NMDA 2B Providers, 2019
FIG. 11 Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Glutamate Receptor Ionotropic NMDA 2B market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
8235

8608

OUR CLIENT